A Phase I Study of an IDO-1 Inhibitor (LY3381916) as Monotherapy and in Combination With an Anti-PD-L1 Antibody (LY3300054) in Patients With Advanced Cancer

Published 2021 View Full Article

Authors

Keywords

Journal

JOURNAL OF IMMUNOTHERAPY

Volume Publish Ahead of Print, Issue -, Pages -

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2021-04-30

DOI

10.1097/cji.0000000000000368

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

JOURNAL OF IMMUNOTHERAPY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Discover Peeref hubs

Become a Peeref-certified reviewer